These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1831816

  • 1. Disposition kinetics of orally administered enoximone in patients with moderate to severe heart failure.
    Ruder MA, Lebsack C, Winkle RA, Mead RH, Smith N, Kates RE.
    J Clin Pharmacol; 1991 Aug; 31(8):702-8. PubMed ID: 1831816
    [Abstract] [Full Text] [Related]

  • 2. Oral enoximone pharmacokinetics in patients with congestive heart failure.
    Lima JJ, Leier CV, Holtz L, Sterechele J, Shields BJ, MacKichan JJ.
    J Clin Pharmacol; 1987 Sep; 27(9):654-60. PubMed ID: 2960700
    [Abstract] [Full Text] [Related]

  • 3. Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite.
    Okerholm RA, Chan KY, Lang JF, Thompson GA, Ruberg SJ.
    Am J Cardiol; 1987 Aug 14; 60(5):21C-26C. PubMed ID: 2956863
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P, Garraffo R, Sbirrazzuoli V, Lapalus P, Morand P.
    Arch Mal Coeur Vaiss; 1990 Sep 14; 83 Spec No 3():75-81. PubMed ID: 2147839
    [Abstract] [Full Text] [Related]

  • 5. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
    Mitrovic V, Petrovic O, Bahavar H, Neuzner J, Dieterich HA, Schlepper M.
    Cardiovasc Drugs Ther; 1991 Aug 14; 5(4):689-95. PubMed ID: 1832289
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of intravenous enoximone in dialysis patients.
    Fiegel P, Trenk D, Jaehnchen E, Dieterich HA.
    J Cardiovasc Pharmacol; 1989 Aug 14; 14 Suppl 1():S20-3. PubMed ID: 2480480
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacology and pharmacokinetics of enoximone].
    Jähnchen E, Trenk D.
    Z Kardiol; 1991 Aug 14; 80 Suppl 4():21-6. PubMed ID: 1833893
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM, Bristow MR, Mason JW.
    Am J Cardiol; 1987 Aug 14; 60(5):57C-62C. PubMed ID: 2956870
    [Abstract] [Full Text] [Related]

  • 12. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G, Butzer F, Dieterich HA, Heinrich F.
    Am J Cardiol; 1987 Aug 14; 60(5):72C-74C. PubMed ID: 2956873
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
    Smith NA, Kates RE, Lebsack C, Ruder MA, Mead RH, Bekele T, Okerholm RA, Rubin GM, Winkle RA.
    Am Heart J; 1991 Sep 14; 122(3 Pt 1):755-63. PubMed ID: 1831585
    [Abstract] [Full Text] [Related]

  • 14. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV, Meiler SE, Matthews S, Unverferth DV.
    Am J Cardiol; 1987 Aug 14; 60(5):27C-30C. PubMed ID: 2956864
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K, Zannad F, Brunotte F, Belhadj K, Juilliere Y, Iannascoli F, Gilgenkrantz JM.
    Am J Cardiol; 1987 Aug 14; 60(5):75C-79C. PubMed ID: 2956874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enoximone. A review of its pharmacological properties and therapeutic potential.
    Vernon MW, Heel RC, Brogden RN.
    Drugs; 1991 Dec 14; 42(6):997-1017. PubMed ID: 1724645
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Weber KT, Janicki JS, Jain MC.
    Am J Cardiol; 1986 Sep 15; 58(7):589-95. PubMed ID: 2944369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.